VintaBio, a biotech manufacturer specializing in high-yield, high-purity viral vectors for gene therapy, today presented data further demonstrating the advantages and productivity of its proprietary ...

Reagent kits can make the transfection process reliable, scalable, cost-effective and standardized — key considerations for viral vector manufacturing. “Without a partner with a deep ...

the 2nd Viral Vector Process Development & Manufacturing Summit is your must-attend meeting in 2024. Secure your place and get your burning questions answered to enhance process intensification ...

and user of viral vectors. However, it is far from a unique opinion in the sector. Most CDMOs working in the space recognize the need for better vector production technologies and have been making ...

Responsible for leadership of viral vector process development and research into new viral vector manufacturing platforms for MassBiologics’ Vector Manufacturing Center. Simultaneous management of ...

Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and ...

Adeno-associated virus (AAV) is rapidly becoming the go-to biological delivery ... these impactful therapies is critical to bringing down costs and accelerating the process from research to ...

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a market size of USD 24.6 Billion by 2032 growing at a CAGR of 18.5% from ...

demonstrate that VintaProcess™ enables enrichment of full capsids at harvest by extending viral vector production using a novel perfusion process, offering a major step forward in simplifying ...

Bristol Myers Squibb plans to close its viral vector production facility in Libertyville, IL according to a BMS spokesperson ...

As an executive leader at OXB James held overall responsibility for a range of key functions including Programme and Alliance Management, Process ... prolific academic viral vector manufacturing ...

VintaBio, a biotech manufacturing technology company specializing in high-yield, high-purity viral vector production for reliable gene therapy access, will present transformative data on its ...